MRNA
Moderna, Inc.
Latest Form 4:Sale$28.7MbyBancel Stephane (Chief Executive Officer) · filed Aug 7, 2026
Moderna, Inc. (MRNA) has 49 SEC Form 4 filings (136 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Aug 31, 2026.
The most active filer is President Hoge Stephen with 4 filings. Insiders have net sold $38.5M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Stéphane Bancel
- Employees:5,800
- HQ:Cambridge, MA, US
- IPO:2018-12-07
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$47.8M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$56.0B
latest known value
Earnings: last 7 quarters
EstimatedActual
| Source | ||||||
|---|---|---|---|---|---|---|
Bancel StephaneFirst filing | Chief Executive Officer | Sale | 499,246 | $28.7M | Aug 7 | SEC ↗ |
| President | Sale | 53,336 | $3.6M | Jul 16 | SEC ↗ | |
| President | Sale | 53,336 | $2.7M | Jun 17 | SEC ↗ | |
Klinger Shannon ThymeFirst in 3 months | Chief Legal Officer | Sale | 3,471 | $174K | Jun 8 | SEC ↗ |
| Director | Sale | 9,263 | $434K | May 22 | SEC ↗ | |
| President | Sale | 53,336 | $2.6M | May 18 | SEC ↗ | |
Hussain AbbasFirst in 5 months | Director | Sale | 5,682 | $265K | May 4 | SEC ↗ |
Klinger Shannon ThymeFirst filing | Chief Legal Officer | Sale | 13,885 | $726K | Mar 3 | SEC ↗ |
Hoge StephenFirst filing | President | Sale | 160,009 | $7.8M | Feb 25 | SEC ↗ |
AFEYAN NOUBARFirst filing | Director | Sale | 23,853 | $703K | Dec 15 | SEC ↗ |
Hussain AbbasFirst filing | Director | Sale | 504 | $14K | Dec 11 | SEC ↗ |
Related companies
Moderna, Inc. is in the Healthcare sector.